Johnson & Johnson has agreed to settle Texas’ lawsuit for the company’s fraudulent marketing of Risperdal. The is the first time J&J has settled a state’s claim for this reason. The settlement comes less than a month after J&J’s $1 billion settlement with the U.S. government.
Read more Discuss →
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.